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1. INTRODUCTION {#ags312281-sec-0005}
===============

Patients with panperitonitis caused by perforation of the digestive and biliary tract require emergency surgery, but their postoperative course is often difficult to manage. High rates of complications and hospital death are usually reported especially in elderly patients.[1](#ags312281-bib-0001){ref-type="ref"}, [2](#ags312281-bib-0002){ref-type="ref"} Several preoperative predictive systems, such as the Calculation of post‐Operative Risk in Emergency Surgery (CORES) score[3](#ags312281-bib-0003){ref-type="ref"} and Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM),[4](#ags312281-bib-0004){ref-type="ref"} have been reported to assess morbidity and mortality in emergency surgery. However, these scoring systems require many variables, including subjective variables such as the American Society of Anesthesiologists (ASA) score, the Japan Coma Scale, or the Glasgow Coma Scale, and are time‐consuming. Moreover, these do not reflect the patient\'s general health status before admission.

In 1989, the term "sarcopenia" was proposed by Irwin Rosenberg to describe the age‐related decline of muscle mass.[5](#ags312281-bib-0005){ref-type="ref"} Sarcopenia is characterized by progressive and generalized loss of skeletal muscle mass and decreased skeletal muscle strength.[6](#ags312281-bib-0006){ref-type="ref"} Sarcopenia is a topic of high interest, and several studies have proven that sarcopenia is an indicator of a patient\'s general health status, such as nutritional and metabolic condition.[7](#ags312281-bib-0007){ref-type="ref"}, [8](#ags312281-bib-0008){ref-type="ref"}, [9](#ags312281-bib-0009){ref-type="ref"}, [10](#ags312281-bib-0010){ref-type="ref"} Although sarcopenia is reportedly a prognostic factor in various conditions such as chronic disease and metabolic disease,[11](#ags312281-bib-0011){ref-type="ref"}, [12](#ags312281-bib-0012){ref-type="ref"}, [13](#ags312281-bib-0013){ref-type="ref"}, [14](#ags312281-bib-0014){ref-type="ref"}, [15](#ags312281-bib-0015){ref-type="ref"}, [16](#ags312281-bib-0016){ref-type="ref"}, [17](#ags312281-bib-0017){ref-type="ref"} it has not been examined in patients with perforation panperitonitis.

In the present study, we evaluated the presence or absence of sarcopenia simply and objectively with the skeletal muscle index (SMI), indicated by the cross‐sectional area (cm^2^) of skeletal muscle in the third lumbar vertebra (L3) region on computed tomography (CT) normalized for height (cm^2^/m^2^).[18](#ags312281-bib-0018){ref-type="ref"} We herein aimed to elucidate the impact of sarcopenia on postoperative complications and mortality in patients with perforation panperitonitis following emergency surgery.

2. METHODS {#ags312281-sec-0006}
==========

2.1. Patients {#ags312281-sec-0007}
-------------

A total of 103 consecutive patients with perforation panperitonitis who underwent emergency surgery from January 2008 to December 2016 at the National Hospital Organization, Beppu Medical Center were retrospectively reviewed. The definition of panperitonitis is contaminated ascites in the entire abdominal cavity from upper abdomen to pelvic floor with confirmation of operative record. Patients were excluded from this analysis if they underwent elective operation, were \<15 years of age, or had injuries caused by trauma. There was no malignancy in any case. All patients underwent preoperative CT within 1 day of their emergency surgery. A transverse CT image at L3 was assessed on each scan. Cross‐sectional areas (cm^2^) of skeletal muscle in the L3 region were measured by outlining them on the CT images. The cross‐sectional areas were then normalized for height (cm^2^/m^2^) to obtain the skeletal muscle index (SMI).[19](#ags312281-bib-0019){ref-type="ref"} Sarcopenia was defined as an SMI of ≤43.75 cm^2^/m^2^ for men and ≤41.10 cm^2^/m^2^ for women based on previously reported cutoff points.[20](#ags312281-bib-0020){ref-type="ref"} The cross‐sectional area of skeletal muscle in the L3 region was measured by two individual researchers (N.K. and S.H.), and no significant difference in the mean value was obtained between them. The software application for sarcopenia evaluation was SYNAPSE Chronical Outlook for Patient\'s Examination Ver. 2.4.1 (SYNAPSE Enterprise‐PACS, Fujifilm Medical, Tokyo, Japan). All preoperative complications were defined as disease with drug treatment. In particular, patients with renal dysfunction had low estimated glomerular filtration (eGFR; \<60 mL/min/1.73 m²) and were diagnosed with chronic renal dysfunction by a nephrologist or physician before hospitalization.

2.2. Study design {#ags312281-sec-0008}
-----------------

The following variables were compared between the patients with and without sarcopenia: patient demographics, ASA score, site of perforation, duration of hospitalization, postoperative complications, and in‐hospital mortality. Postoperative complications were graded according to the Clavien‐Dindo classification.[21](#ags312281-bib-0021){ref-type="ref"} Postoperative complications were defined as grade ≥II complications. Severe postoperative complications were defined as grade ≥IIIb complications (those requiring surgical intervention). The predictive factors were examined with respect to severe complications and in‐hospital mortality.

This study was approved by the institutional review board of the National Hospital Organization, Beppu Medical Center (2015‐027). It was carried out in compliance with the Helsinki Declaration and the International Conference on Harmonization of Guidelines for Good Clinical Practice.

2.3. Statistical analysis {#ags312281-sec-0009}
-------------------------

Groups were compared using the Wilcoxon rank‐sum test (Mann‐Whitney *U*‐test). Categorical data were compared using the chi‐squared test or Fisher\'s exact test. Univariate and multivariate logistic regression analyses were carried out to control for variables that may confound the effect of sarcopenia on severe postoperative complications and mortality, with all parameters having a *P* value \<.050 on univariate analysis included in a multivariate model. Univariate and multivariate associations are reported as odds ratio (OR) with its 95% confidence interval (CI). Receiver operating characteristic (ROC) curves were used to determine or predict severe complications and in‐hospital mortality. Areas under the ROC curves (AUC) were compared, and the cutoff levels were determined at an optimized accuracy with equal weight given to sensitivity and specificity errors. A *P* value of \<.050 was considered statistically significant. All statistical analyses were carried out using JMP Pro 12.0 (SAS Inc., Cary, NC, USA).

3. RESULTS {#ags312281-sec-0010}
==========

Of 103 patients, 50 (48.5%) had sarcopenia. Characteristics of patients with and without sarcopenia are shown in Table [1](#ags312281-tbl-0001){ref-type="table"}. Women had a significantly higher rate of sarcopenia than men. Patients with sarcopenia had higher C‐reactive protein (CRP) than those without sarcopenia. Other factors such as age, white blood cell count (WBC), ASA score, preoperative complications except diabetes mellitus, site of perforation, and hospital stay were not related to sarcopenia. Complications (Clavien‐Dindo grade ≥II), severe complications (Clavien‐Dindo grade ≥IIIb) and in‐hospital mortality were more frequently observed in patients with sarcopenia than in those without (68.0% vs 45.3%, *P* = .019; 28.0% vs 9.4%, *P* = .015; and 20.0% vs 5.7%, *P* = .029, respectively). Details of postoperative complications are shown in Table [2](#ags312281-tbl-0002){ref-type="table"}. There was no statistical difference between the groups.

###### 

Characteristics of patients with and without sarcopenia

  Demographics                                With sarcopenia (n = 50)   Without sarcopenia (n = 53)   *P* value
  ------------------------------------------- -------------------------- ----------------------------- -----------
  Age (y)                                     67.6 ± 17.4                68.6 ± 15.8                   .76
  Gender                                                                                               
  Male                                        17 (34)                    31 (58)                       .013
  Female                                      33 (66)                    22 (42)                       
  Laboratory data                                                                                      
  WBC (/mL)                                   10 162 ± 5539              9086 ± 5878                   .342
  CRP (mg/dL)                                 14.7 ± 10.9                10.4 ± 10.7                   .046
  SMI (cm²/m²)                                35.7 ± 4.1                 49.4 ± 5.1                    \<.001
  ASA score                                                                                            
  1                                           5 (10)                     5 (9)                         .207
  2                                           14 (28)                    8 (15)                        
  3                                           28 (56)                    36 (68)                       
  4                                           3 (6)                      4 (8)                         
  Preoperative complications                                                                           
  Circulatory disease                         17 (34)                    18 (34)                       1
  Respiratory disease                         5 (10)                     7 (13)                        .634
  Liver disease                               1 (2)                      3 (6)                         .304
  Renal dysfunction                           12 (24)                    9 (17)                        .378
  Diabetes mellitus                           0 (0)                      7 (13)                        .008
  Collagen disease                            6 (12)                     2 (4)                         .132
  Site of perforation                                                                                  
  Stomach and duodenum                        20 (40)                    19 (36)                       .797
  Small bowel and appendix                    12 (24)                    14 (26)                       .907
  Colon and rectum                            17 (34)                    16 (30)                       .806
  Biliary tract                               0 (0)                      3 (6)                         .079
  Uterus abscess                              1 (2)                      1 (2)                         1
  Postoperative outcomes                                                                               
  Hospital stay (days)                        38.4 ± 33.3                36.4 ± 35.9                   .78
  Complication (C‐D grade **≥**II)            34 (68)                    24 (45)                       .019
  Severe complication (C‐D grade **≥**IIIb)   14 (28)                    5 (9)                         .015
  In‐hospital mortality                       10 (20)                    3 (6)                         .029

Normally distributed variables are presented as mean ± SD. Values in parentheses are percentages.

ASA, American Society of Anesthesiologists; C‐D, Clavien‐Dindo classification; CRP, C‐reactive protein; SMI, skeletal muscle index; WBC, white blood cells.
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###### 

Details of postoperative complications in patients with and without sarcopenia

  Factor                            With sarcopenia (n = 50)   Without sarcopenia (n = 53)   *P* value[a](#ags312281-note-0005){ref-type="fn"}
  --------------------------------- -------------------------- ----------------------------- ---------------------------------------------------
  Surgical site infection                                                                    
  Superficial and deep incisional                                                            
  II                                0                          3                             1
  IIIa                              7                          4                             
  IIIb                              0                          1                             
  Organ space                                                                                
  II                                0                          1                             .087
  IIIa                              4                          1                             
  IV                                1                          0                             
  V                                 2                          0                             
  Anastomotic leakage                                                                        
  II                                1                          0                             1
  IIIa                              1                          2                             
  IIIb                              1                          1                             
  V                                 1                          1                             
  Ileus                                                                                      
  II                                0                          1                             .496
  IIIa                              0                          1                             
  Pneumonia                                                                                  
  II                                2                          2                             .31
  IIIa                              1                          1                             
  IV                                1                          0                             
  V                                 2                          0                             
  Pleural effusion                                                                           
  IIIa                              1                          0                             .111
  IV                                1                          0                             
  V                                 1                          0                             
  Atelectasis                                                                                
  IIIa                              1                          0                             .485
  Pneumothorax                                                                               
  V                                 1                          0                             .485
  SIADH                                                                                      
  II                                0                          1                             1
  Brain infarction                                                                           
  II                                1                          0                             .485
  Deep venous thrombosis                                                                     
  IV                                2                          0                             .233
  Intra‐abdominal bleeding                                                                   
  IIIa                              1                          0                             .485
  Gastrointestinal bleeding                                                                  
  IIIa                              1                          0                             .61
  IV                                0                          1                             
  V                                 1                          0                             
  Gastrointestinal perforation                                                               
  V                                 1                          0                             .485
  Enterocolitis                                                                              
  II                                0                          2                             .496
  Cholecystitis                                                                              
  II                                0                          1                             1
  Spondyloarthritis                                                                          
  IIIa                              1                          0                             .485
  Candidemia                                                                                 
  II                                0                          2                             1
  V                                 1                          0                             
  Septic shock                                                                               
  IIIa                              0                          2                             1
  IV                                2                          1                             
  V                                 1                          0                             
  DIC                                                                                        
  II                                1                          3                             .716
  IIIa                              2                          1                             
  V                                 0                          1                             
  Cardiac failure                                                                            
  II                                1                          1                             1
  Renal failure                                                                              
  V                                 1                          0                             .485
  Multiple organ failure                                                                     
  IIIa                              0                          1                             .428
  IV                                1                          0                             
  V                                 3                          1                             

Complications were graded according to the Clavien‐Dindo classification. Some patients had two or more complications.

DIC, disseminated intravascular coagulation; SIADH, syndrome of inappropriate antidiuretic hormone.

Postoperative complications (Clavien‐Dindo grade ≥II) were compared between the two groups with Fisher\'s exact test.
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Univariate and multivariate analyses showed that severe complications were significantly associated with age (OR, 11.72; 95% CI, 2.30‐59.88; *P* = .003), sarcopenia (OR, 4.41; 95% CI, 1.27‐15.34; *P* = .020), and renal dysfunction (OR, 5.77; 95% CI, 1.61‐20.73; *P* = .007) (Table [3](#ags312281-tbl-0003){ref-type="table"}). In univariate analysis, significant prognostic factors for in‐hospital mortality were age, sarcopenia, circulatory disease, respiratory disease, and renal dysfunction. Multivariate analysis identified age (OR, 15.07; 95% CI, 1.49‐152.92; *P* = .022), sarcopenia (OR, 5.43; 95% CI, 1.08‐27.34; *P* = .040), and renal dysfunction (OR, 13.08; 95% CI, 2.56‐66.76; *P* = .002) as independent prognostic factors for in‐hospital mortality (Table [4](#ags312281-tbl-0004){ref-type="table"}).

###### 

Factors associated with severe complications

                               Univariate analysis   Multivariate analysis                                 
  ---------------------------- --------------------- ----------------------- -------- ------- ------------ ------
  Age                          9.35                  2.03‐43.03              \<.001   11.72   2.30‐59.88   .003
  Male                         0.61                  0.22‐1.71               .35                            
  WBC                          0.8                   0.29‐2.19               .664                           
  CRP                          1.41                  0.52‐3.83               .497                           
  Sarcopenia                   3.73                  1.23‐11.31              .015     4.41    1.27‐15.34   .02
  ASA score                    1.33                  0.43‐4.06               .62                            
  Preoperative complications                                                                               
  Circulatory disease          2.01                  0.73‐5.53               .173                           
  Respiratory disease          2.53                  0.68‐9.50               .157                           
  Liver disease                0                     0‐0                     .332                           
  Renal dysfunction            5.4                   1.82‐16.03              .001     5.77    1.61‐20.73   .007
  Diabetes mellitus            0                     0‐0                     .192                           
  Collagen disease             2.96                  0.64‐13.67              .148                           
  Perforation site                                                                                         
  Stomach and duodenum         0.95                  0.34‐2.66               .919                           
  Small bowel and appendix     0.5                   0.13‐1.87               .301                           
  Colon and rectum             2.25                  0.81‐6.22               .118                           
  Biliary tract                0                     0‐0                     .403                           
  Uterus abscess               0                     0‐0                     .497                           

ASA, American Society of Anesthesiologists; CI, confidence interval; CRP, C‐reactive protein, OR, odds ratio; WBC, white blood cells.
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###### 

Factors associated with mortality

                               Univariate analysis   Multivariate analysis                                  
  ---------------------------- --------------------- ----------------------- -------- ------- ------------- ------
  Age                          12                    1.50‐96.19              .004     15.07   1.49‐152.92   .022
  Male                         0.68                  0.21‐2.25               .53                             
  WBC                          1.39                  0.43‐4.48               .575                            
  CRP                          3.08                  0.88‐10.75              .068                            
  Sarcopenia                   4.67                  1.07‐16.16              .029     5.43    1.08‐27.34    .04
  ASA score                    2.75                  0.57‐13.21              .19                             
  Preoperative complications                                                                                
  Circulatory disease          3.73                  1.12‐12.46              .025     1.16    0.23‐5.88     .856
  Respiratory disease          4.56                  1.14‐18.17              .022     7.51    0.91‐61.76    .061
  Liver disease                0                     0‐0                     .438                            
  Renal dysfunction            9.48                  2.68‐33.49              \<.001   13.08   2.56‐66.76    .002
  Diabetes mellitus            0                     0‐0                     .298                            
  Collagen disease             2.55                  0.46‐14.20              .272                            
  Perforation site                                                                                          
  Stomach and duodenum         1.03                  0.31‐3.40               .962                            
  Small bowel and appendix     0.22                  0.027‐1.75              .084                            
  Colon and rectum             2.87                  0.88‐9.36               .081                            
  Biliary tract                0                     0‐0                     .504                            
  Uterus abscess               0                     0‐0                     .587                            

ASA, American Society of Anesthesiologists; CI, confidence interval; CRP, C‐reactive protein, OR, odds ratio; WBC, white blood cells.

John Wiley & Sons, Ltd

Receiver operating characteristic curves for predicting severe complications and optimal cutoff levels for age and sarcopenia were ≥79 years for age (sensitivity, 74%; specificity, 77%) and \<38 cm^2^/m^2^ for SMI (sensitivity, 69%; specificity, 74%), respectively (Figure [1](#ags312281-fig-0001){ref-type="fig"}). ROC curves for predicting in‐hospital mortality and optimal cutoff levels for age and sarcopenia were ≥79 years (sensitivity, 77%; specificity, 74%) and \<38 cm^2^/m^2^ for SMI (sensitivity, 62%; specificity, 82%), respectively (Figure [2](#ags312281-fig-0002){ref-type="fig"}).

![Receiver operating characteristic (ROC) analyses for prediction of severe complications with age and skeletal muscle index (SMI). A, ROC curve analysis shows that an optimal cutoff level of age is \>79 y (sensitivity, 74%; specificity, 77%). Area under the ROC curve is 0.76. B, ROC curve analysis shows that an optimal cutoff level of SMI is \<38 cm^2^/m^2^ (sensitivity, 69%; specificity, 74%). Area under the ROC curve is 0.74](AGS3-3-630-g001){#ags312281-fig-0001}

![Receiver operating characteristic (ROC) analyses for prediction of in‐hospital mortality with age and skeletal muscle index (SMI). A, ROC curve analysis shows that an optimal cutoff level of age is \>79 y (sensitivity, 77%; specificity, 74%). Area under the ROC curve is 0.78. B, ROC curve analysis shows that an optimal cutoff level of SMI is \<38 cm^2^/m^2^ (sensitivity, 62%; specificity, 82%). Area under the ROC curve is 0.78](AGS3-3-630-g002){#ags312281-fig-0002}

Distributions of age and SMI in patients with and without severe complications and mortality are indicated in Figure [3](#ags312281-fig-0003){ref-type="fig"}. If an age of ≥79 years and an SMI of \<38 cm^2^/m^2^ were used as the thresholds to predict severe complications and in‐hospital mortality, the rate of severe complications was 71% (sensitivity, 77%; specificity, 96%) and the rate of in‐hospital mortality was 57% (sensitivity, 62%; specificity, 94%).

![Distribution of age and skeletal muscle index (SMI) in patients with or without severe complications (A) and in‐hospital mortality (B). If age ≥79 y and SMI \<38 cm^2^/m^2^ were used as the thresholds to predict severe complications (A) and in‐hospital mortality (B), the rate of severe complications was 71% (sensitivity, 77%; specificity, 96%) and the rate of in‐hospital mortality was 57% (sensitivity, 62%; specificity, 94%). Thresholds of 79 y and 38 cm^2^/m^2^ are indicated by solid lines](AGS3-3-630-g003){#ags312281-fig-0003}

4. DISCUSSION {#ags312281-sec-0011}
=============

Sarcopenia, characterized by progressive and generalized loss of skeletal muscle mass and decreased skeletal muscle strength, have proven to represent the general health status of patients.[7](#ags312281-bib-0007){ref-type="ref"}, [8](#ags312281-bib-0008){ref-type="ref"}, [9](#ags312281-bib-0009){ref-type="ref"}, [10](#ags312281-bib-0010){ref-type="ref"} The European Working Group on Sarcopenia in Older People recommends defining sarcopenia by both loss of muscle volume and decreased muscle function.[6](#ags312281-bib-0006){ref-type="ref"} Although sarcopenia is associated with aging, it can also develop as a consequence of chronic disease or malignancy. For this reason, many definitions of sarcopenia have been established for various target cohorts such as ethnic groups and age groups.[22](#ags312281-bib-0022){ref-type="ref"} In the emergency setting, skeletal muscle function is difficult to evaluate and, thus, in the present study, muscle mass determined by CT images was measured. CT images, which are feasible in the emergency setting and completely objective, are usually carried out preoperatively for all patients with perforation panperitonitis. Because adjustment of skeletal muscle volume using body weight and body surface area[23](#ags312281-bib-0023){ref-type="ref"} is difficult in the emergency setting, we judged that using body height only was appropriate in the present study.

In the present study, sarcopenia was determined using SMI cutoff levels specific to each gender (≤43.75 and ≤41.10 cm^2^/m^2^ for men and women, respectively), based on a previous report with Japanese patients.[20](#ags312281-bib-0020){ref-type="ref"} Univariate and multivariate logistic regression models identified sarcopenia as an independent predictor of severe complications and in‐hospital mortality. When we examined the optimal cutoff of SMI for predicting severe complications and in‐hospital mortality, the optimal cutoffs of SMI were \<38 cm^2^/m^2^ for both severe complications and mortality, regardless of gender. Using the common cutoff for both genders is simple and beneficial when preparing for emergency surgery. In patients with severe sarcopenia, as indicated by SMI \<38 cm^2^/m^2^, the rates of complications, severe complications and in‐hospital mortality were 76%, 35% and 26%, respectively ([Table S1](#ags312281-sup-0001){ref-type="supplementary-material"}).

Between 2000 and 2050, the world\'s population aged over 60 years will expand from 11% to 20%.[19](#ags312281-bib-0019){ref-type="ref"} Especially in Japan, the population aged over 65 years had already exceed 25% in 2015 and is expected to account for 38% of the population in 2050. Surgical procedures are thus being increasingly carried out in elderly patients. A prospective study with 4315 elective noncardiac procedures reported that elderly patients were at increasing risk of postoperative complications and in‐hospital mortality; the rates of postoperative complications and in‐hospital mortality in patients aged ≥80 years were 12.5% and 2.6%, respectively, and even in patients aged ≥80 years, in‐hospital mortality was low.[24](#ags312281-bib-0024){ref-type="ref"} A retrospective study with of 593 abdominal emergency surgeries showed that 30 day‐mortality and 90 day‐mortality were 10% and 17%, respectively, and that age was an independent risk factor of mortality.[25](#ags312281-bib-0025){ref-type="ref"} The present cohort with perforation panperitonitis indicated that age was an independent predictive factor of both severe complications and in‐hospital mortality and that patients aged ≥79 years, as an optimal cutoff, had severe complications of 43.8% and in‐hospital mortality of 31.3%. The age effect on morbidity and mortality may be more pronounced in emergency surgery, especially for perforation panperitonitis, than in elective surgery. In addition, because of the wide heterogeneity of general health status and the scarcity of objective tools for predicting operative risks, surgical decision‐making for emergency surgery is challenging in elderly patients. In the present study, among the patients aged ≥79 years, those with SMI \<38 cm^2^/m^2^ had a severe complication rate of 71% and an in‐hospital mortality rate of 57%, whereas those with SMI ≥38 cm^2^/m^2^ had a severe complication rate of 22% (*P* = .011) and an in‐hospital mortality rate of 11% (*P* = .008). Among the patients aged \<79 years, those with SMI \<38 cm^2^/m^2^ had a severe complication rate of 15% and an in‐hospital mortality rate of 5%, and those with SMI ≥38 cm^2^/m^2^ had a severe complication rate of 4% (*P* = .132) and an in‐hospital mortality rate of 4% (*P* = 1.000). In a previous study of emergency abdominal surgery, sarcopenia significantly predicted mortality in univariate analysis but lost significance in multivariate analysis when factors such as age and ASA were included.[25](#ags312281-bib-0025){ref-type="ref"} In that study, the mean age was 61 years, but in the present study, it was 68 years and with 32 (33%) of the 103 patients aged ≥79 years. The impact of sarcopenia on surgical outcomes following emergency surgery may be less in younger patients than in elderly patients. Estimation of sarcopenia using SMI by CT images is thus likely to discriminate patients eligible or not eligible for emergency surgery among elderly patients with perforation panperitonitis.

Patients with sarcopenia had a higher incidence of complications and severe complications than those without sarcopenia. Postoperative complications observed in the present study may have been caused by a lack of multiple skeletal muscle functions. Skeletal muscle was recently identified as an endocrine organ and associated with immune regulation, glucose disposal, and protein synthesis.[26](#ags312281-bib-0026){ref-type="ref"}, [27](#ags312281-bib-0027){ref-type="ref"} Glutamine, an important nutrient for the integrity of the intestinal wall, is mainly synthesized in skeletal muscle. Sarcopenia is associated with reduced glutamine production, leading to intestinal dysfunction and infectious complications.[10](#ags312281-bib-0010){ref-type="ref"} Cytokine interleukin‐6 is secreted from skeletal muscle, promotes muscle hypertrophy, and enhances insulin‐stimulated glucose uptake. Sarcopenia may result in glucose intolerance because \>75% of glucose is managed by skeletal muscle.[7](#ags312281-bib-0007){ref-type="ref"}, [8](#ags312281-bib-0008){ref-type="ref"}, [9](#ags312281-bib-0009){ref-type="ref"}, [10](#ags312281-bib-0010){ref-type="ref"} A high blood glucose concentration is associated with delayed wound healing and infectious complications.[28](#ags312281-bib-0028){ref-type="ref"}, [29](#ags312281-bib-0029){ref-type="ref"} These factors may be related to a higher tendency of surgical site infection of the organ space and pneumonia after emergency surgery in patients with sarcopenia, although there was no significant difference between the two groups in the present study. In addition, respiratory complications were found more frequently in 11 (50%) patients with sarcopenia compared with three (6%) patients without sarcopenia (*P* = .021). Sarcopenia has been reported as a risk factor for pneumonia because of poor chewing and swallowing function, delayed mobilization, dysphagia, or difficulty in clearing the airway.[30](#ags312281-bib-0030){ref-type="ref"}

Although the present study has several limitations because of its retrospective design and small number of patients, we believe that sarcopenia is a predictive factor of severe complications and in‐hospital mortality following emergency surgery for perforation panperitonitis, especially in elderly patients. Estimation of sarcopenia using CT images and body height is simple and objective, and therefore convenient for the emergency setting. Rates of severe complications and in‐hospital mortality were extremely high in patients aged ≥79 years and with SMI \<38 cm^2^/m^2^, but even in patients aged ≥79 years, those with SMI ≥38 cm^2^/m^2^ had better surgical outcomes. Estimation of sarcopenia is likely to identify patients eligible for emergency surgery among elderly patients with perforation panperitonitis. Evaluation of sarcopenia may identify patients susceptible to surgical stress and it may lead to the development of tailored preventive strategies and allocation of medical resources in the coming aging society.
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